A data revolution is underway in modern biological science, now that obtaining the genome sequence has become routine and increasingly affordable.
The Neural Coding Group has a broad interest in systems neuroscience spanning areas such as sensory coding, adaptation and behaviour.
We aim to understand complex molecular processes by which these transcription factors interact with signal transduction pathways, chromatin and RNA.
We are interested in how the mammalian brain processes sensory information received from the external world.
The Synaptic Mechanisms Laboratory investigates how individual synapses in the central nervous system function and how they are modulated.
The Bruestle Group - Inflammatory T Cell Responses, is focusing on different T helper cell subsets and how they modulate immunity in diverse autoimmune mouse models.
By studying how the CRISPR/Cas systems have evolved and diversified against bacteriophage invasion, our laboratory seeks to develop new gene-editing tools.
The focus of our research is understanding how to generate effective immunity against the malaria parasite Plasmodium.
Seeking to understand the genetic etiology and cellular pathogenesis of human diseases arising from dysregulated immunity.
The Dehorter Group aims to determine how interneurons shape neuronal networks activity and contribute to circuits balance in health and disease.
We study the cellular mechanisms involved in cytoplasmic calcium signalling, with a focus on the surface membrane of skeletal and cardiac muscle fibres.
The main focus of the lab is to investigate novel pathways regulating B cell development and function.
The Eyras Group is working to understand the biology of RNA and cancer using computational methods.
The Fischer lab investigates the connection between chromatin structure, pervasive transcription and RNA surveillance, and their influence on genomic stability.
The group investigates the molecular basis of processes coordinated by platelets across vascular biology.
This group focuses on the molecular analysis of major pro-malignant transcription factor networks that operate in cancer cells using an integrated approach.
We are interested in learning gene expression control mechanisms through the lens of host-transposon interaction and how they play roles in animal development.
The Horikawa group studies the molecular mechanisms of development and activation of normal and malignant lymphocytes.
Identifying genetic variants in individuals which predispose to autoimmunity and immune- or non immune-mediated kidney disease.
Our Group elucidate the molecular mechanisms underlying phototransduction and adaptation - the conversion of light into a neural signal and subsequent recovery
Develop novel bioimaging instruments and informatics tools to explore, discover and profile 3D cell shape under flow with optics and machine learning.
Dr Li is a molecular pharmacologist and osteoimmunologist with interests in understanding the processes that control a ‘foreign body reaction or response’ initiated by biomaterials implanted into bone or exposed to human bone cells.
Lipotek is a developer of targeted vaccine delivery and adjuvant technologies.
My interest in the optical designs of invertebrate eyes led me to study how visual systems squeeze real-time information into brains of limited capacity
The Man Group investigates the role of innate immunity in infectious diseases and cancer.
The main focus of our research is to understand the host response to malarial infection.
Our lab studies a number of retinal diseases, with our main focus on finding novel diagnostics and treatment options for Age-Related Macular Degeneration (AMD).
The Cancer and Vascular Biology Group has been working for a number of years on the molecular basis of cell adhesion, cell migration and cell invasion.
Our group studies the mechanisms and transcriptome-wide patterns of eukaryotic mRNA translation and its regulation by RNA-binding proteins and non-coding RNA.
The Quinn Group's current research involves generating genetic models using Drosophila melanogaster to understand the initiation and progression of human cancer
Our laboratory focuses on understanding the problems associated with HIV vaccine failure in humans and exploring different vaccine routes.
The Schulte Group investigates therapy options arising from the nucleolar stress response.
Our main approach is to precisely define the types of rapid cell responses by analysing the gene-specific levels of translation.
We propose that during T1D development, neutrophils are activated by platelets to release NETs/histones inside blood vessels and within islets.
The Soboleva Group studies mechanisms by which epigenetics controls cell differentiation and how those processes are affected in cancer.
The Neuronal Signalling Group studies the electrical and chemical signals that nerve cells in the brain use to communicate with one another.
Our lab studies the molecular mechanisms of epithelial tissue development, tissue regeneration and carcinoma formation.
Chromatin and transcriptional regulation during development
Our research interests are Immunity to virus infection and in particular CD8+ T cells, poxviruses and herpesviruses and antigen presentation.
My research has been focused on degenerative diseases of the retina, from the molecular and cellular level to the clinical.
Investigating cellular and molecular events that regulate production and selection versus elimination of memory B cells.
The Wen Group is a new computational biology lab of RNA and functional genomics, Department of Genome Sciences, The John Curtin School of Medical Research, ANU.